A significant higher expression of LINK‐A was noted in stage‐III TNBC tissues compared to non‐neoplastic adjacent breast tissues, and tissues obtained from other subset of breast cancers (ERPR+/HER2+, HER2‐/ERPR+, AND ERPR‐/HER2+). Here, ERBB2 is linked to breast carcinoma.